Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients

S. Poletajew, B. Braticevici, A. Brisuda, V. Cauni, V. Grygorenko, MZ. Lesnyak, J. Lisiński, C. Persu, K. Renk, P. Radziszewski,

. 2015 ; 68 (1) : 9-14.

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023694

INTRODUCTION: Time that passes between an unfavourable diagnosis to a radical cystectomy (RC) affects oncological outcomes in patients with bladder cancer. Unsatisfactory survival of patients after RC in Central Europe can potentially result from this factor. MATERIAL AND METHODS: The aim of this study was to assess the time interval between transurethral resection of the bladder tumor (TURBT) and RC in Central Europe and to identify clinical factors of possible delays. 941 consecutive patients who underwent RC in nine Central European urological centers were enrolled into the study. After the TURBT-RC time was calculated, selected clinical and pathological parameters were tested as potential factors influencing the timing of RC. RESULTS: On average, RCs were performed 73.8 days after TURBTs (median - 53, range 0-1587). In 238 patients (25.3%) the time exceeded 12 weeks. Patients with muscle-invasive cancer were operated earlier on than patients with nonmuscle-invasive cancer (67.6 vs.105.2 days, RR = 1.41, p = 0.00). In high volume centers (>30 RC per year) longer TURBT-RC intervals were observed (97.6 vs. 66.3 days, RR = 2.49, p = 0.00). Simultaneously, factors such as female sex (RR = 1.21), more advanced age of patient (>65 years, RR = 1.23), presence of concomitant CIS (RR = 2.43), grade of cancer cells (RR = 1.67) and final post-RC stage (RR = 1.51) had no statistically significant effect on the results (p >0.05). CONCLUSIONS: The mean time interval between the diagnosis and radical treatment of patients with bladder cancer in Central Europe is adequate. However, there are still a relatively high number of patients waiting for radical cystectomy longer than 8 weeks. A lower stage of disease as well as a higher case load within of a hospital may delay the surgery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023694
003      
CZ-PrNML
005      
20150730100749.0
007      
ta
008      
150709s2015 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5173/ceju.2015.01.444 $2 doi
035    __
$a (PubMed)26029471
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Poletajew, Sławomir $u Medical University of Warsaw, Department of Urology, Warsaw, Poland.
245    10
$a Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients / $c S. Poletajew, B. Braticevici, A. Brisuda, V. Cauni, V. Grygorenko, MZ. Lesnyak, J. Lisiński, C. Persu, K. Renk, P. Radziszewski,
520    9_
$a INTRODUCTION: Time that passes between an unfavourable diagnosis to a radical cystectomy (RC) affects oncological outcomes in patients with bladder cancer. Unsatisfactory survival of patients after RC in Central Europe can potentially result from this factor. MATERIAL AND METHODS: The aim of this study was to assess the time interval between transurethral resection of the bladder tumor (TURBT) and RC in Central Europe and to identify clinical factors of possible delays. 941 consecutive patients who underwent RC in nine Central European urological centers were enrolled into the study. After the TURBT-RC time was calculated, selected clinical and pathological parameters were tested as potential factors influencing the timing of RC. RESULTS: On average, RCs were performed 73.8 days after TURBTs (median - 53, range 0-1587). In 238 patients (25.3%) the time exceeded 12 weeks. Patients with muscle-invasive cancer were operated earlier on than patients with nonmuscle-invasive cancer (67.6 vs.105.2 days, RR = 1.41, p = 0.00). In high volume centers (>30 RC per year) longer TURBT-RC intervals were observed (97.6 vs. 66.3 days, RR = 2.49, p = 0.00). Simultaneously, factors such as female sex (RR = 1.21), more advanced age of patient (>65 years, RR = 1.23), presence of concomitant CIS (RR = 2.43), grade of cancer cells (RR = 1.67) and final post-RC stage (RR = 1.51) had no statistically significant effect on the results (p >0.05). CONCLUSIONS: The mean time interval between the diagnosis and radical treatment of patients with bladder cancer in Central Europe is adequate. However, there are still a relatively high number of patients waiting for radical cystectomy longer than 8 weeks. A lower stage of disease as well as a higher case load within of a hospital may delay the surgery.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Braticevici, Bogdan $u Burghele Clinical Hospital, Department of Urology, Bucharest, Romania.
700    1_
$a Brisuda, Antonín $u Charles University, 2nd Faculty of Medicine, Teaching Hospital in Motol, Department of Urology, Prague, Czech Republic.
700    1_
$a Cauni, Victor $u Colentina Clinical Hospital, Department of Urology, Bucharest, Romania.
700    1_
$a Grygorenko, Viacheslav $u National Academy of Medical Sciences of Ukraine, Institute of Urology, Department of Restorative Urology and Newest Technology, Kyiv, Ukraine.
700    1_
$a Lesnyak, Martyn-Zenovii $u Lviv Regional Clinical Hospital, Department of Urology, Lviv, Ukraine.
700    1_
$a Lisiński, Janusz $u Pomeranian Medical University, Department of Urology and Urological Oncology, Szczecin, Poland.
700    1_
$a Persu, Cristian $u Carol Davila Medical University, Department of Urology, Bucharest, Romania.
700    1_
$a Renk, Kacper $u Ceynowa Hospital, Department of Urology, Wejherowo, Poland.
700    1_
$a Radziszewski, Piotr $u Medical University of Warsaw, Department of Urology, Warsaw, Poland.
773    0_
$w MED00183832 $t Central European journal of urology $x 2080-4806 $g Roč. 68, č. 1 (2015), s. 9-14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26029471 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150730100837 $b ABA008
999    __
$a ind $b bmc $g 1084026 $s 906687
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 68 $c 1 $d 9-14 $i 2080-4806 $m Central European journal of urology $n Cent European J Urol $x MED00183832
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace